Clonal hematopoiesis of indeterminate potential
Clonal hematopoiesis of indeterminate potential has been studied in 6 papers since 2023: 6 observational studies in people; 4 in the past year. The newest paper, Aug 31, 2026: “Age-related clonal hematopoiesis and mosaic sex chromosome loss define distinct systemic proteomic programs and disease vulnerabilities”.
6 papers study it13 findingsUpdated
See all 6 papers on clonal hematopoiesis of indeterminate potential
At a glance
The findings reach people, from one lab or study. 4 independent labs in 4 countries.
“non-DNMT3A CHIP was associated with broad multisystem disease burden”
1 of its findings points the other way.
- 4 independent labs in 4 countries
- 1 finding against
- Funders: National Institutes of Health and others
- Humans6
What did studies of clonal hematopoiesis of indeterminate potential find?
1Studies of clonal hematopoiesis of indeterminate potential measured one outcome, myocardial fibrosis.
Myocardial fibrosis
upin humans1OR 1.31
1 study
Myocardial fibrosis
upin humans1OR 1.31
Clonal hematopoiesis of indeterminate potential is linked with higher myocardial fibrosis in humans (OR 1.31 (95% CI 1.07-1.59) for top quintile).
“Large CHIP was associated with 1.31-fold odds (95% CI 1.07-1.59; P = .009) of being in the top quintile of myocardial fibrosis by CMR.”
Humansheartvariant allele fraction ≥10%n = 9,191
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
European heart journal
What is clonal hematopoiesis of indeterminate potential linked with?
11Studies link clonal hematopoiesis of indeterminate potential with 11 measures, among them intracerebral hemorrhage, myeloid immune regulation and multisystem diseases.
Intracerebral hemorrhage
downin humans1upin humans1
1 study
Intracerebral hemorrhage
downin humans1upin humans1
Clonal hematopoiesis of indeterminate potential is linked with a lower risk of intracerebral hemorrhage in humans (JAK2 subtype).
“JAK2-CHIP exhibited inverse associations with intracerebral hemorrhage and atrial fibrillation”
HumansJAK2 subtype
Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk
Frontiers in neurology
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of intracerebral hemorrhage in humans (ASXL1 subtype).
“ASXL1-CHIP also showed directional risk elevations for intracerebral hemorrhage and hypertension.”
HumansASXL1 subtype
Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk
Frontiers in neurology
myeloid immune regulation
upin humans1
1 study
myeloid immune regulation
upin humans1
Clonal hematopoiesis of indeterminate potential is associated with myeloid immune regulation in humans.
“non-DNMT3A CHIP to myeloid immune regulation”
Humansnon-DNMT3A
medRxivPreprint
Multisystem diseases
upin humans1
1 study
Multisystem diseases
upin humans1
Clonal hematopoiesis of indeterminate potential is associated with multisystem diseases in humans.
“non-DNMT3A CHIP was associated with broad multisystem disease burden”
Humansnon-DNMT3A
medRxivPreprint
Kidney failure
upin humans1HR 1.9
1 study
Kidney failure
upin humans1HR 1.9
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of kidney failure in patients with CKD, KNOW-CKD cohort, multivariable Cox regression (adjusted HR 1.90 (95% CI 1.03 to 3.51)).
“CHIP was associated with higher risk of KF (adjusted hazard ratio, 1.90; 95% confidence interval, 1.03 to 3.51)”
Humansin patients with CKD, KNOW-CKD cohort, multivariable Cox regressionmedian follow-up 10.0 years
Clinical journal of the American Society of Nephrology : CJASN
Atrial fibrillation
upin humans1
1 study
Atrial fibrillation
upin humans1
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of atrial fibrillation in humans (DNMT3A subtype).
“DNMT3A-CHIP was positively associated with atrial fibrillation”
HumansDNMT3A subtype
Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk
Frontiers in neurology
Ischemic stroke
upin humans1
1 study
Ischemic stroke
upin humans1
Clonal hematopoiesis of indeterminate potential is associated with ischemic stroke in humans (TET2 subtype).
“TET2-CHIP showed the clearest cerebrovascular signal, with significant associations with ischemic stroke, intracerebral hemorrhage, and hypertension.”
HumansTET2 subtype
Subtype-specific effects of clonal hematopoiesis on cerebrovascular and cardiometabolic disease risk
Frontiers in neurology
Cardiac arrhythmia
upin humans1
1 study
Cardiac arrhythmia
upin humans1
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of cardiac arrhythmia in humans (driven by non-DNMT3A driver genes).
“Gene-specific analyses revealed an increased risk of arrhythmias across driver genes other than DNMT3A.”
Humansdriven by non-DNMT3A driver genes
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
European heart journal
Ventricular arrhythmia
upin humans1HR 1.16
1 study
Ventricular arrhythmia
upin humans1HR 1.16
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of ventricular arrhythmia in humans (HR 1.16 (95% CI 1.00-1.34); large CHIP HR 1.22 (95% CI 1.03-1.45)).
“1.16 (95% CI, 1.00-1.34; P = .049) and 1.22 (95% CI 1.03-1.45; P = .021) for ventricular arrhythmias”
Humansvariant allele fraction ≥2%
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
European heart journal
Bradyarrhythmia
upin humans1HR 1.09
1 study
Bradyarrhythmia
upin humans1HR 1.09
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of bradyarrhythmia in humans (HR 1.09 (95% CI 1.01-1.19); large CHIP HR 1.13 (95% CI 1.03-1.25)).
“1.09 (95% CI 1.01-1.19; P = .031) and 1.13 (95% CI 1.03-1.25; P = .011) for bradyarrhythmias”
Humansvariant allele fraction ≥2%
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
European heart journal
Supraventricular arrhythmia
upin humans1HR 1.11
1 study
Supraventricular arrhythmia
upin humans1HR 1.11
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of supraventricular arrhythmia in humans (HR 1.11 (95% CI 1.04-1.18); large CHIP HR 1.13 (95% CI 1.05-1.22)).
“Any and large CHIP were associated with multi-variable-adjusted hazard ratios of 1.11 [95% confidence interval (CI) 1.04-1.18; P = .001] and 1.13 (95% CI 1.05-1.22; P = .001) for supraventricular arrhythmias”
Humansvariant allele fraction ≥2%n = 13,892
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
European heart journal
All 11Fewer
Funding
1 grant since 2026National Heart, Lung, and Blood Institute$55.1K